Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Survivorship from pediatric and adult brain tumors: The 2024 Brain Tumor Epidemiology Consortium meeting report

  • Scott L. Coven
  • , Roberta McKean-Cowdin
  • , Michael E. Scheurer
  • , Kimberly J. Johnson
  • , Luc Bauchet
  • , Carol Kruchko
  • , Ching C. Lau
  • , Quinn T. Ostrom
  • , John Villano
  • , Yan Yuan
  • , Friederike Erdmann

Producción científica: Articlerevisión exhaustiva

Resumen

The BrainTumor Epidemiology Consortium (BTEC) is an international organization with membership of individuals from the scientific community with interests related to brain tumor epidemiology, including surveillance, classification, methodology, etiology, and factors associated with morbidity and survival.The 2024 annual BTEC meeting entitled “Survivorship from Pediatric and Adult BrainTumors” was held in Mainz, Germany, USA, on May 15–17, 2024. The meeting gathered scientists from Africa, Australia, Europe, and North America and included 4 keynote sessions focusing on brain tumor survivorship across the age spectrum.The meeting included 3 abstract sessions, which also included scientific talks around brain tumor risk factors and predicting risk and survival. We also held a brainstorming session to form a near-term research strategy around brain tumor survivorship in the epidemiology community.This report provides a summary of the meeting content.

Idioma originalEnglish
Número de artículovdaf095
PublicaciónNeuro-Oncology Advances
Volumen7
N.º1
DOI
EstadoPublished - ene 1 2025

Nota bibliográfica

Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

Financiación

The Brain Tumor Epidemiology Consortium (BTEC) was founded in 2003 following a meeting sponsored by the U.S. National Cancer Institute’s (NCI) Division of Cancer Epidemiology and Genetics and the U.S. National Institutes of Health’s (NIH) Office of Rare Diseases. In 2013, BTEC was incorporated as a nonprofit with 501(c)(3) status. The 2024 annual meeting was held in Mainz, Germany, on May 15–17 and was titled “ Survivorship from Pediatric and Adult Brain Tumors .” The program committee included Board of Director members: co-Presidents Michael Scheurer, PhD, MPH and Yan Yuan, PhD; co-Vice-Presidents Jon Foss-Skiftesvik, MD and Roberta McKean-Cowdin, PhD, MPH; Treasurer Quinn Ostrom, PhD, MPH; and Secretary Carol Kruchko. Presentations included eight keynote addresses and 22 oral abstract presentations including two American Brain Tumor Association (ABTA) Junior Investigator Award presentations (US and non-US). Ms. Bénédicte Clement of Montpellier, France, was the meeting coordinator. In this report, we briefly summarize the meeting content. Abstracts can be found at https://sites.usc.edu/braintumorcause/program-with-abstracts-btec-mainz-2024/ . We would like to thank the generous meeting support of the American Brain Tumor Association ( https://www.abta.org/ ) and the Uncle Kory Foundation ( https://www.unclekory.org ). Additional funding for this conference was made possible (in part) by R13CA290955 (PI Q. Ostrom) from the National Cancer Institute. Acknowledgments

Financiadores
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer Institute
National Cancer Institute Division of Cancer Epidemiology and Genetics
Brain Tumor Epidemiology Consortium

    ASJC Scopus subject areas

    • Surgery
    • Oncology
    • Clinical Neurology

    Huella

    Profundice en los temas de investigación de 'Survivorship from pediatric and adult brain tumors: The 2024 Brain Tumor Epidemiology Consortium meeting report'. En conjunto forman una huella única.

    Citar esto